Analytical Data
-
基因名
IER2
- Application
-
别名
IER2；ETR101；PIP92；Immediate early response gene 2 Protein
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BTL4
-
表达区间
1-223aa
-
氨基酸序列
MEVQKEAQRIMTLSVWKMYHSRMQRGGLRLHRSLQLSLVMRSARELYLSAKVEALEPEVSLPAALPSDPRLHPPREAESTAETATPDGEHPFPEPMDTQEAPTAEETSACCAPRPAKVSRKRRSSSLSDGGDAGLVPSKKARLEEKEEEEGASSEVADRLQPPPAQAEGAFPNLARVLQRRFSGLLNCSPAAPPTAPPACEAKPACRPADSMLNVLVRAVVAF
-
分子量
24.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IER2 (Immediate Early Response 2) is a protein that plays a crucial role in cellular responses to various stimuli, including stress and growth factors. Initially identified as an immediate early gene, IER2 is involved in vital processes such as cell proliferation, differentiation, and apoptosis. Research has indicated that IER2 may be implicated in various physiological and pathological conditions, including cancer, where its expression levels are often altered. Understanding the molecular mechanisms underlying IER2 function is essential for deciphering its role in disease progression and developing potential therapeutic strategies. To further investigate IER2, researchers have focused on the generation of recombinant IER2 proteins, enabling in-depth studies of its structure, function, and interactions with other cellular components. By producing IER2 in a controlled laboratory setting, scientists can explore its biochemical properties and potential as a biomarker or therapeutic target. This recombinant approach also facilitates high-throughput screening for small molecules that may modulate IER2 activity, offering insights into its therapeutic potential. Overall, the study of recombinant IER2 is not only vital for understanding its biological significance but also holds promise for the development of innovative treatments for diseases associated with its dysregulation.
